Managing hypertrophic cardiomyopathy in clinical practice: The patient journey
August 31, 2024
10:00 - 10:45 BST
Perry Elliott, MD
Roberto Barriales-Villa, MD, PhD
Iacopo Olivotto, MD
Strategies for managing hyperkalemia in cardiorenal disease: A clinical dialogue defining a roadmap to improved outcomes
15:15 - 16:00 BST
Gianluigi Savarese, MD
Aaron Wong, MD
James Burton, MD
Innovating the clinical management of LDL-c: Exploring CETP as therapeutic target
August 30, 2024
Prof. Kausik Ray, MBChB, MD, MPhil
danilo norata
John Kastelein, MD, PhD
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Evaluation of the complex cardiac pathophysiology in HCM
Ahmad Masri, MD, MS
Recommendations on the management of HCM in guidelines: European vs. American views
Myosin inhibitors: recent clinical data and applications in HCM and HF
Caroline Coats, MD
Optimizing clinical care in patients with cardiorenal disease for achieving long term goals
Clara Bonanad Lozano, MD, PhD
Implementing the latest evidence on novel potassium binders for achieving long term goals
Early intervention & long-term success: Navigating hyperkalemia in cardiorenal disease
Recognizing and diagnosing heart failure in patients with HCM
Aleš Linhart, MD, PhD
Evidence-based novel therapies in HCM
Michelle Michels, MD
The weight of cardiovascular risk: Addressing obesity in cardiac patients
Naveed Sattar, MD, PhD
John Deanfield, MD
Martha Gulati, MD
Why cardiologists should be interested in obesity and its treatment
Obesity: A looming cardiovascular threat – Pathophysiology, diagnosis and impact
Discussion
ACC 2024: What's Really New in Electrophysiology That Will Change My Practice?
Manesh R. Patel, MD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.